«Bartter Syndrome

Below is an extended Bartter Syndrome patents listing. Click here to return to the Bartter Syndrome main in depth entry.

Patents :
US Patent No.	Title
6492496	Antibodies to the receptor protein designated 2F1
6926898	Albumin fusion proteins
6946134	Albumin fusion proteins
6951924	Antibodies against secreted protein HTEBYII
6984734	Cyclo[n]pyrroles and methods thereto
6994857	Albumin fusion proteins
7001599	Methods for treating inflammation with 2F1 antibody
7026447	53 human secreted proteins
7045505	Methods of using 69039, a novel human Na/Ca exchanger family member
7056685	Receptor ligands and methods of modulating receptors
7071183	Use of inhibitors of the renin-angiotensin system
6919433	Antibodies to protein HPMBQ91
6905688	Albumin fusion proteins
6884771	Angiotensin converting enzyme homolog and uses therefor
6627649	Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin V receptors, even of V1 a and V2 receptors
6641847	Cranberry seed oil extract and compositions containing components thereof
6709855	Methods for detection and use of differentially expressed genes in disease states
6753164	Nucleic acids encoding human serpin polypeptide HMCIS41
6767917	Amorphous torasemide modification
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
6794143	Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
6800455	Secreted factors
6833379	Crystal modification of torasemide
6878806	Human secreted protein HTEEB42
7074573	CLCKb mutation as a diagnostic therapeutical target
7091315	Protein HDPBQ71
7250442	Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
7253271	BSND nucleic acids and proteins
7306911	Methods for assessing risk for cardiac dysrythmia in a human subject
7329490	Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7368444	N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7381800	Antibodies to HBIMF63 polypeptide
7411051	Antibodies to HDPPA04 polypeptide
7241782	Polymorph V of torasemide
7238667	Albumin fusion proteins
7238660	Albumin fusion proteins
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7160729	Method for detecting diseases that are associated with defects of cystic fibrosis transmembrane conductance regulator (CFTR) protein
7163797	50 human secreted proteins
7176280	Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
7183075	Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7202344	Secreted factors
7235238	Antibodies that bind receptor protein designated 2F1
7235364	CICKb mutation as a diagnostic and therapeutical target
7411072	Tricyclic steroid hormone nuclear receptor modulators

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.